ONCR-177

N/A

Report date: 2024/01/02 20:03:52

Base Information

Drug NameONCR-177
Drug Alias NameONCR-177
ClassificationBiologics > Oncolytic virusCell and gene therapy > Gene therapy
Mechanisms of ActionInterleukin-12 stimulantsFms-related tyrosine kinase 3 ligand stimulantsC-C motif chemokine 4 stimulants +[5] 
TargetsInterleukin-12Fms-related tyrosine kinase 3 ligandC-C motif chemokine 4 +[5] 
Therapy Area/IndicationsSolid tumoursSkin NeoplasmsLiver Neoplasms +[9] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesOncorus Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOncorus Inc
Active IndicationsN/A
Inactive IndicationsSolid tumoursSkin NeoplasmsLiver Neoplasms +[9] 

Other Information

ATC CodeN/A
Related LinksN/A